It's Time You
Stood Out

Boost your Chronic Care Management and separate yourself from the competition by adding this missing, Medicare-backed piece to your medication therapy management program. 

Boost your CCM program

Take advantage of a new Medicare Part B benefit that helps you and your provider pool:

Improve Quality
of Care

Increase MIP Score

Reduce Adverse Drug Reactions

Differentiate your CCM/MTM Service

Increase patient retention

What’s the
missing piece? 

Medicare has issued Gravity a code that covers Comprehensive Pharmacogenetic Testing (PGx) to help guide prescription and dosage decisions.  

How does this help me?

Adding PGx to the Medication Therapy Management component of your CCM can raise your program’s value
by improving quality of care in three ways:


Protects patients by:

- Avoiding preventable ADRs 

- Reducing medications 

- Improving therapeutic outcomes 

- Increasing patient adherence to MTM 


Protects practices by:

- Generating a PGx test results report that highlights: 

  1. Drugs with FDA gene-drug warning labels 

  2. Drugs most often implicated in adverse drug reactions with gene-drug implications 


Improve MIPS Quality Measures by:

- Reducing hospital admission rate for patients with multiple chronic conditions 

- Reducing unplanned cardiovascular admission rates 

- Reducing all-cause unplanned readmissions 


How does it work?  

  • We identify patients who are taking one or more of the 26 most dangerous drugs to prescribe without PGx guidance in accordance with the FDA but are deemed medically necessary. 
  • Once patients are identified and medical necessity confirmed, the Provider adds PGx test to CCM treatment plan
  • We assist with sample collection and obtain necessary patient information for Medicare billing
  • We submit PGx Report results to patient(s) EMR, highlighting any potential drug-gene risk
  • Provider consults PGx report to see if any alternative drug/dose regimen is necessary 

Simple, Compliant & Compassionate Addition to Your CCM Program

Improves Care  

Improved Quality Measures  

Reduces Risk  

Covered and Endorsed by Medicare 

Female Patient Being Reassured By Doctor In Hospital Room

Ready to separate yourself from the pack?

Schedule a call today and learn how to differentiate your CCM program from your competitors.

Why risk it when there’s a better way? 

All medications approved by the FDA pose a certain amount of risk. Some are riskier than others. And some don’t seem to work at all. Why is that?

For any medication to be safe and effective, it must:


1. Be absorbed and used by the body


2. Have the right “drug concentration + blood plasma” ratio to be effective


3. Affect its specific target in a cell (e.g. an enzyme) or cell function (e.g. cell growth)


4. Remain unaffected by other medications in the bloodstream

Discovering the “Goldilocks” Medications  

Genetic variation is what makes us all unique. The color of your hair, your eyes, even your height are all due to this genetic variance. It’s how your genes express themselves.

Medications fail to work—or cause unwanted and uncomfortable side effects—because an individual’s unique genetic variance doesn’t express the right proteins (found in genes) in the right amount to metabolize the drug as expected. 


91% of people have at least 1 genetic variance 


Trial & (Avoidable) Error 

We’re so used to taking whatever medication our providers prescribe. And if the first medicine they order doesn’t work, we go back to the office hoping they’ll prescribe a different one. Not only is this “trial & error” process costly in both time and money, it can be dangerous, even life-threatening.